|
CA2244744A1
(en)
*
|
1996-02-01 |
1997-08-07 |
University Of Florida |
Lyst1 and lyst2 gene compositions and methods of use
|
|
EP1194542A1
(en)
|
1999-03-02 |
2002-04-10 |
Ludwig Institute For Cancer Research |
Cloning of cdna of mage's 5,8,9 and 11 and their uses in diagnosis of cancer
|
|
EP1242049A4
(en)
|
1999-12-13 |
2005-01-05 |
Epimmune Inc |
VACCINE COMPOSITIONS AND ANTIGEN PEPTIDES ASSOCIATED WITH CLASS I HLA-A2 TUMOR
|
|
CA2417570C
(en)
|
2000-07-31 |
2010-12-07 |
Kyogo Itoh |
Tumor-specific t cell activation by peptide antigens
|
|
AU2003226141A1
(en)
|
2002-03-27 |
2003-10-13 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Method for treating cancer in humans
|
|
DE10225139A1
(de)
|
2002-05-29 |
2004-02-26 |
Immatics Biotechnologies Gmbh |
Verfahren zur Identifizierung von immunreaktiven Peptiden
|
|
DE10225144A1
(de)
|
2002-05-29 |
2003-12-18 |
Immatics Biotechnologies Gmbh |
An MHC-Moleküle bindende Tumor-assoziierte Peptide
|
|
DE10313819A1
(de)
|
2003-03-24 |
2004-10-07 |
Immatics Biotechnologies Gmbh |
An MHC-Moleküle bindende Tumor-assoziierte Peptide
|
|
US7807392B1
(en)
|
2003-09-15 |
2010-10-05 |
Celera Corporation |
Lung disease targets and uses thereof
|
|
WO2005076009A2
(en)
|
2004-01-28 |
2005-08-18 |
Immatics Biotechnologies Gmbh |
Method for identifying and quantifying of tumour-associated peptides
|
|
DE102004026135A1
(de)
|
2004-05-25 |
2006-01-05 |
Immatics Biotechnologies Gmbh |
An MHC-Moleküle bindende Tumor-assoziierte Peptide
|
|
WO2012079878A2
(en)
|
2010-12-14 |
2012-06-21 |
Immatics Biotechnologies Gmbh |
Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
|
|
JP2008532014A
(ja)
|
2005-02-24 |
2008-08-14 |
セマインズ，インコーポレイティド |
生物試料を分類するための組成物及び方法
|
|
EP1717245B1
(en)
|
2005-04-26 |
2011-06-08 |
Immatics Biotechnologies GmbH |
T-cell epitopes from the oncofetal antigen-immature laminin receptor protein and medical uses thereof
|
|
EP1760089B1
(en)
|
2005-09-05 |
2009-08-19 |
Immatics Biotechnologies GmbH |
Tumor-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules and related anti-cancer vaccine
|
|
ATE461215T1
(de)
|
2005-09-05 |
2010-04-15 |
Immatics Biotechnologies Gmbh |
Tumor-assoziierte peptide, welche an unterschiedliche menschliche leukozytenantigene der klasse ii binden
|
|
WO2008053573A1
(fr)
|
2006-10-30 |
2008-05-08 |
National University Corporation Hokkaido University |
Remède pour néoplasme malin
|
|
HUE032379T2
(en)
|
2007-07-27 |
2017-09-28 |
Immatics Biotechnologies Gmbh |
Composition of tumour-associated peptides and related anti-cancer vaccine
|
|
RS54147B1
(sr)
|
2007-07-27 |
2015-12-31 |
Immatics Biotechnologies Gmbh |
Nova imunoterapija protiv tumora mozga
|
|
KR101351195B1
(ko)
|
2007-07-27 |
2014-01-14 |
이매틱스 바이오테크놀로지스 게엠베하 |
면역 치료를 위한 새로운 면역원성 에피톱
|
|
DK2288700T3
(en)
*
|
2008-05-09 |
2017-05-22 |
Agency Science Tech & Res |
HBV EPITOP-REACTIVE EXOGEN T-CELL RECEPTOR (TCR) AND APPLICATIONS THEREOF
|
|
PL2119726T5
(pl)
|
2008-05-14 |
2018-04-30 |
Immatics Biotechnologies Gmbh |
Nowe i silne peptydy MHC klasy II pochodzące z surwiwiny i neurokanu
|
|
TW201008574A
(en)
|
2008-08-19 |
2010-03-01 |
Oncotherapy Science Inc |
INHBB epitope peptides and vaccines containing the same
|
|
WO2010037395A2
(en)
|
2008-10-01 |
2010-04-08 |
Dako Denmark A/S |
Mhc multimers in cancer vaccines and immune monitoring
|
|
PL2172211T3
(pl)
|
2008-10-01 |
2015-05-29 |
Immatics Biotechnologies Gmbh |
Kompozycja związanych z guzem peptydów i związana z tym szczepionka przeciwrakowa do leczenia glejaka (GBM) i innych rodzajów raka
|
|
GB0917094D0
(en)
*
|
2009-09-29 |
2009-11-11 |
Ucl Biomedica Plc |
T-cell receptor
|
|
WO2011066265A1
(en)
|
2009-11-25 |
2011-06-03 |
Ludwig Institute For Cancer Research Ltd. |
Cancer testis antigens as biomarkers in non-small cell lung cancer
|
|
US9023802B2
(en)
|
2009-12-14 |
2015-05-05 |
Immatics Biotechnologies Gmbh |
HLA-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
|
|
GB201019331D0
(en)
|
2010-03-19 |
2010-12-29 |
Immatics Biotechnologies Gmbh |
Methods for the diagnosis and treatment of cancer based on AVL9
|
|
GB201004575D0
(en)
|
2010-03-19 |
2010-05-05 |
Immatics Biotechnologies Gmbh |
Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers
|
|
GB201004551D0
(en)
|
2010-03-19 |
2010-05-05 |
Immatics Biotechnologies Gmbh |
NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
|
|
GB201006360D0
(en)
|
2010-04-16 |
2010-06-02 |
Immatics Biotechnologies Gmbh |
Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development
|
|
US9114100B2
(en)
|
2010-05-17 |
2015-08-25 |
Duke University |
Methods of treatment using ex vivo expansion of cord blood T cells
|
|
GB201009222D0
(en)
|
2010-06-02 |
2010-07-21 |
Immatics Biotechnologies Gmbh |
Improved cancer therapy based on tumour associated antigens derived from cyclin D1
|
|
CN101870725B
(zh)
|
2010-06-29 |
2012-06-27 |
郑州大学 |
Mage-4抗肿瘤ctl表位肽及其应用
|
|
GB201015765D0
(en)
|
2010-09-21 |
2010-10-27 |
Immatics Biotechnologies Gmbh |
Use of myeloid cell biomarkers for the diagnosis of cancer
|
|
GB201021289D0
(en)
|
2010-12-15 |
2011-01-26 |
Immatics Biotechnologies Gmbh |
Novel biomarkers for a prediction of the outcome of an immunotherapy against cancer
|
|
AU2012302778B2
(en)
|
2011-08-31 |
2016-11-24 |
Mie University |
Vaccine preparation for cancer treatment
|
|
GB2508414A
(en)
|
2012-11-30 |
2014-06-04 |
Max Delbrueck Centrum |
Tumour specific T cell receptors (TCRs)
|
|
WO2014153470A2
(en)
|
2013-03-21 |
2014-09-25 |
Sangamo Biosciences, Inc. |
Targeted disruption of t cell receptor genes using engineered zinc finger protein nucleases
|
|
TWI714869B
(zh)
|
2013-08-05 |
2021-01-01 |
德商伊瑪提克斯生物科技有限公司 |
新穎肽類，細胞及其用於治療多種腫瘤的用途，其製造方法及包含其等之醫藥組成物
|
|
PE20150600A1
(es)
|
2013-10-15 |
2015-06-03 |
Vignolo Carlos Alberto Ibanez |
CICLO - BICICLETA HIBRIDA MOTORIZADA 2 x 2
|
|
GB201319446D0
(en)
|
2013-11-04 |
2013-12-18 |
Immatics Biotechnologies Gmbh |
Personalized immunotherapy against several neuronal and brain tumors
|
|
GB201408255D0
(en)
|
2014-05-09 |
2014-06-25 |
Immatics Biotechnologies Gmbh |
Novel immunotherapy against several tumours of the blood, such as acute myeloid leukemia (AML)
|
|
WO2015172843A1
(en)
|
2014-05-16 |
2015-11-19 |
Biontech Diagnostics Gmbh |
Methods and kits for the diagnosis of cancer
|
|
GB201411037D0
(en)
|
2014-06-20 |
2014-08-06 |
Immatics Biotechnologies Gmbh |
Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemai (CLL)
|
|
GB2528124A
(en)
|
2014-07-11 |
2016-01-13 |
Nec Corp |
Communication system
|
|
CA2963364A1
(en)
|
2014-10-02 |
2016-04-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of isolating t cells having antigenic specificity for a cancer-specific mutation
|
|
TWI617841B
(zh)
|
2014-10-22 |
2018-03-11 |
英特爾股份有限公司 |
用於光學系統的防雲紋圖樣擴散器
|
|
WO2016064317A1
(en)
|
2014-10-24 |
2016-04-28 |
Telefonaktiebolaget L M Ericsson (Publ) |
Method and arrangement for csi-rs transmission
|
|
CN104460328B
(zh)
|
2014-10-29 |
2019-05-10 |
小米科技有限责任公司 |
基于设定场景模式的智能设备控制方法和装置
|
|
DE102014016105A1
(de)
|
2014-10-30 |
2016-05-04 |
Head Technology Gmbh |
Superelastische Schlägersaite
|
|
PH12021551513A1
(en)
|
2014-10-30 |
2024-06-03 |
EcoGensus LLC |
Solid fuel composition formed from mixed solid waste
|
|
MA40904A
(fr)
|
2014-11-03 |
2017-09-12 |
Hygeia Tech Inc |
Compositions d'ester de phorbol et procédés pour traiter ou réduire la durée d'une cytopénie
|
|
WO2016071343A1
(en)
|
2014-11-03 |
2016-05-12 |
Immures S.R.L. |
T cell receptors
|
|
EP3215069B1
(en)
|
2014-11-04 |
2023-03-08 |
Spinal Stabilization Technologies LLC |
Percutaneous implantable nuclear prosthesis
|
|
US10543081B2
(en)
|
2014-11-17 |
2020-01-28 |
Mitrassist Medical Ltd. |
Heart valve prosthesis
|
|
JP6336210B2
(ja)
|
2014-11-20 |
2018-06-06 |
アーベーベー シュヴァイツ アクツィエンゲゼルシャフト |
金属製造工程における電磁ブレーキシステムおよび溶融金属流動の制御方法
|
|
DE102014223758A1
(de)
|
2014-11-20 |
2016-05-25 |
Windmöller & Hölscher Kg |
Kontaktwalze
|
|
GB201501017D0
(en)
|
2014-12-23 |
2015-03-04 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
|
|
GB201423361D0
(en)
|
2014-12-30 |
2015-02-11 |
Immatics Biotechnologies Gmbh |
Method for the absolute Quantification of naturally processed HLA-Restricted cancer peptides
|
|
EP3067366A1
(en)
|
2015-03-13 |
2016-09-14 |
Max-Delbrück-Centrum Für Molekulare Medizin |
Combined T cell receptor gene therapy of cancer against MHC I and MHC II-restricted epitopes of the tumor antigen NY-ESO-1
|
|
GB201504502D0
(en)
|
2015-03-17 |
2015-04-29 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
|
|
GB201505305D0
(en)
|
2015-03-27 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel Peptides and combination of peptides for use in immunotherapy against various tumors
|
|
GB201505585D0
(en)
|
2015-03-31 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers
|
|
GB201507030D0
(en)
|
2015-04-24 |
2015-06-10 |
Immatics Biotechnologies Gmbh |
Immunotherapy against lung cancers, in particular NSCLC
|
|
GB201507719D0
(en)
|
2015-05-06 |
2015-06-17 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
|
|
GB201510771D0
(en)
|
2015-06-19 |
2015-08-05 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer
|
|
GB201511191D0
(en)
|
2015-06-25 |
2015-08-12 |
Immatics Biotechnologies Gmbh |
T-cell epitopes for the immunotherapy of myeloma
|
|
GB201511546D0
(en)
|
2015-07-01 |
2015-08-12 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
|
|
GB201511792D0
(en)
|
2015-07-06 |
2015-08-19 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against esopageal cancer and other cancers
|
|
MY189596A
(en)
|
2015-07-15 |
2022-02-18 |
Immatics Biotechnologies Gmbh |
A novel peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
|
|
GB201513921D0
(en)
|
2015-08-05 |
2015-09-23 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
|
|
GB201515321D0
(en)
|
2015-08-28 |
2015-10-14 |
Immatics Biotechnologies Gmbh |
Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
|
|
GB201517538D0
(en)
|
2015-10-05 |
2015-11-18 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
|
|
HK1258444A1
(zh)
|
2015-10-09 |
2019-11-15 |
Immatics Biotechnologies Gmbh |
抗wt1/hla特异性抗体
|
|
CN105219714A
(zh)
|
2015-10-20 |
2016-01-06 |
上海隆耀生物科技有限公司 |
一种用于激活肺癌特异性免疫反应的试剂盒
|
|
GB201521746D0
(en)
|
2015-12-10 |
2016-01-27 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against CLL and other cancers
|
|
GB201521894D0
(en)
|
2015-12-11 |
2016-01-27 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against various cancers
|
|
GB201522667D0
(en)
|
2015-12-22 |
2016-02-03 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
|
|
GB201604458D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against cancers
|
|
DE102016123893A1
(de)
|
2016-12-08 |
2018-06-14 |
Immatics Biotechnologies Gmbh |
T-Zellrezeptoren mit verbesserter Bindung
|
|
DE102016123859B3
(de)
|
2016-12-08 |
2018-03-01 |
Immatics Biotechnologies Gmbh |
Neue T-Zellrezeptoren und deren Verwendung in Immuntherapie
|
|
DE102016123847B3
(de)
|
2016-12-08 |
2018-04-05 |
Immatics Biotechnologies Gmbh |
Neue T-Zellrezeptoren und deren Verwendung in Immuntherapie
|
|
BR112019028280A2
(pt)
|
2017-07-04 |
2020-07-14 |
Curevac Ag |
moléculas de ácido nucleico
|
|
MX2020001879A
(es)
|
2017-08-18 |
2020-07-29 |
Gritstone Oncology Inc |
Proteínas de fijación al antígeno que se dirigen a antígenos compartidos.
|
|
WO2019051001A1
(en)
|
2017-09-06 |
2019-03-14 |
California Institute Of Technology |
SIGNALING AND BIFUNCTIONAL RECEPTORS HAVING ANTIGENS (SABR)
|
|
US11866731B2
(en)
|
2017-11-10 |
2024-01-09 |
Chineo Medical Technology Co., Ltd |
Modified immune cells and uses thereof
|
|
JP2021508475A
(ja)
|
2017-12-28 |
2021-03-11 |
グリットストーン オンコロジー インコーポレイテッド |
共有抗原を標的とする抗原結合タンパク質
|
|
SI3773689T1
(sl)
|
2018-04-11 |
2023-02-28 |
Enterome S.A. |
Antigenski peptidi za preprečevanje in zdravljenje raka
|
|
CA3100775A1
(en)
|
2018-05-18 |
2019-11-21 |
Children's National Medical Center |
Improved targeted t-cell therapy
|
|
TW202000907A
(zh)
|
2018-05-23 |
2020-01-01 |
美商葛利史東腫瘤科技公司 |
共有抗原
|
|
EP3802614A1
(en)
|
2018-06-04 |
2021-04-14 |
Apo-T B.V. |
Methods and means for attracting immune effector cells to tumor cells
|
|
GB201819540D0
(en)
|
2018-11-30 |
2019-01-16 |
Adaptimmune Ltd |
T cell modification
|
|
CN114375301B
(zh)
|
2019-05-08 |
2025-08-05 |
基因医疗免疫疗法有限责任公司 |
工程改造的t细胞
|
|
EP3986938A4
(en)
|
2019-06-18 |
2023-06-28 |
Regeneron Pharmaceuticals, Inc. |
Mage-a4 t cell receptors and methods of use thereof
|